Articles

14/09/2022

Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients

13/09/2022

Reshaping the Pharmaceutical API Industry with Digital Transformation

02/08/2022

7 Ways how Active Pharmaceutical Ingredients (APIs) Enable Indian Pharmaceutical Companies to Grow

02/08/2022

How is the Indian Pharmaceutical industry gearing up for 2022-2023?

Impact of COVID-19 on Indian HPAPI industry

The synthesis of active pharmaceutical ingredients (APIs) using continuous flow chemistry

30/11/2021

Dr. Reddy's approach to Environmental Management

ANVISA Certification of GMP Pharmaceutical Ingredients for 61 of Dr Reddy’s APIs

07/07/2021

Managing the Product Life Cycle: Naproxen API and formulations

27/05/2021

Understanding Active Pharmaceutical Ingredients: CPHI talk by Dr. Ramani Susarla

31/03/2021

EMA Nitrosamine Guidance – Deadline March 31, 2021

26/11/2020

Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021

19/11/2020

Dr. Reddy's research publication on simultaneous automated image analysis and Raman spectroscopy of powders at an individual particle level

02/09/2020

COVID-19 and What’s Next for API Sourcing?

14/09/2020

A Paradigm Shift that Is Here to Stay - Sauri Gudlavalleti speaks to CME Manager on COVID-19 response

07/09/2020

A Year of Challenge and Opportunity - Deepak Sapra, Global Head of PSAI speaks to The Medicine Maker

25/08/2020

Indian healthcare reform offers thriving pharmaceutical market opportunities: Interview with Deepak Sapra

01/06/2020

Dr. Reddy’s is improving supply chain performance for Pregabalin API through large manufacturing capacity and backward integration

01/12/2019

Enhancing Supply Chain Security for Levetiracetam API